Cancer researchers at the University of California, San Francisco (UCSF) have discovered a molecular mechanism that may help explain how tumors form and progress. The team, led by Dr. Vivek Mittal, Associate Professor of Medicine at UCSF, found that a protein called WIPI1 plays a critical role in regulating the growth and metastasis of cancer cells.

WIPI1 (WD-repeat protein interacting with phosphoinositides) is a protein that is involved in several cellular processes, including autophagy, a process by which cells break down and recycle their own components. Autophagy is important for maintaining cellular homeostasis and preventing the accumulation of damaged proteins and organelles that can contribute to cancer development.

In their study, published in the journal Nature Cell Biology, the UCSF team found that WIPI1 levels were significantly reduced in cancer cells compared to normal cells. This reduction in WIPI1 was associated with increased cell proliferation and metastasis, suggesting that WIPI1 may play a tumor suppressor role.

To further investigate the role of WIPI1 in cancer, the researchers used mouse models of cancer. They found that mice with reduced WIPI1 levels developed more aggressive tumors and were more likely to develop metastasis than mice with normal WIPI1 levels.

The team also found that WIPI1 regulates the expression of several genes that are involved in cell cycle progression and metastasis. This suggests that WIPI1 may function as a master regulator of cancer cell growth and spread.

"Our findings suggest that WIPI1 plays a critical role in preventing cancer development and progression," said Dr. Mittal. "Understanding how WIPI1 regulates cell growth and metastasis may lead to new therapeutic strategies for cancer treatment."

The researchers plan to further investigate the role of WIPI1 in cancer and to develop new drugs that target WIPI1 to prevent or treat cancer.